Composition
- Active ingredients
- DEFLAZACORT 22.75MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DEFLAZACORT 30MG · TabletANDA217741-003 · Prescription
- DEFLAZACORT 6MG · TabletANDA217741-001 · Prescription
- DEFLAZACORT 36MG · TabletANDA217741-004 · Prescription
- DEFLAZACORT 18MG · TabletANDA217741-002 · Prescription
- DEFLAZACORT 6MG · TabletANDA217173-001 · Prescription
- DEFLAZACORT 36MG · TabletANDA217173-004 · Prescription
- DEFLAZACORT 18MG · TabletANDA217173-002 · Prescription
- DEFLAZACORT 30MG · TabletANDA217173-003 · Prescription
- DEFLAZACORT 22.75MG/ML · SuspensionANDA217813-001 · Prescription
- DEFLAZACORT 22.75MG/ML · SuspensionANDA219930-001 · Prescription
- DEFLAZACORT 6MG · TabletANDA216720-001 · Prescription
- DEFLAZACORT 36MG · TabletANDA216720-004 · Prescription
- DEFLAZACORT 18MG · TabletANDA216720-002 · Prescription
- DEFLAZACORT 30MG · Tablet
At a glance
- Brand name
- Deflazacort
- Route
- Oral
- Dosage form
- Suspension
- Applicant
- Upsher Smith Labs
- Status
- Prescription
- FDA approval
- 11 Aug 2025
- Application
- ANDA216992-001